Research has long suggested that omega-3 fatty acids found in fish oil may have a positive impact on cardiovascular health and type 2 diabetes. However, the exact mechanisms by which these fatty acids affect insulin resistance, especially in non-obese individuals, remain poorly understood. A recent study published in the journal Nutrients has shed new light on this topic, revealing that fish oil supplementation may help switch off inflammation-driven insulin resistance in rats with non-obese type 2 diabetes.

The study, conducted by researchers at the Butantan Institute’s Education Center in Brazil, focused on Goto-Kakizaki (GK) rats, a well-established animal model used to study non-obese type 2 diabetes. Type 2 diabetes is characterized by high blood sugar levels due to insulin resistance, where the body’s cells become less responsive to insulin, the hormone responsible for glucose uptake. The study aimed to investigate whether fish oil supplementation could reduce insulin resistance and improve blood sugar control in these rats.

To achieve this, the researchers administered fish oil at a dose of 2 grams per kilogram of body weight to the GK rats three times a week for eight weeks. The treated animals showed significant improvements in insulin sensitivity, blood sugar control, and inflammatory markers. Notably, the fish oil supplementation reduced the expression of pro-inflammatory cytokines and increased the production of anti-inflammatory cytokines, which are crucial for modulating the immune response.

The study’s findings are significant because they suggest that fish oil may work by modulating the immune response, reducing inflammation, and improving insulin sensitivity in non-obese type 2 diabetes. This is in line with previous research that has shown that omega-3 fatty acids can reduce inflammation and improve insulin sensitivity in obese individuals. However, this study highlights the potential benefits of fish oil supplementation in non-obese individuals with type 2 diabetes, a group that is often overlooked in the treatment and management of the disease.

The researchers also noted that the fish oil supplementation had a profound impact on the immune system, reducing the polarization of Th1 and Th17 cells, which are pro-inflammatory lymphocyte subtypes, and increasing the percentage of regulatory T-cells (Tregs), which are anti-inflammatory in nature. This shift in the immune response is crucial for reducing inflammation and improving insulin sensitivity.

While the study’s findings are promising, it is essential to note that the results were obtained from preclinical experiments and may not directly translate to humans. However, the study provides valuable insights into the potential mechanisms by which fish oil supplementation may affect insulin resistance and blood sugar control in non-obese individuals with type 2 diabetes. Further research is needed to confirm these findings and explore the potential benefits of fish oil supplementation in humans.

The study’s lead author, Rui Curi, noted that obesity is a major risk factor for type 2 diabetes, but it is not the only factor. In people who develop diabetes without obesity, genetic factors may play a significant role, and other factors such as delayed intestinal transit may also contribute to insulin resistance. The study highlights the importance of exploring the complex interplay between metabolic and immune factors in the development and management of type 2 diabetes.

In conclusion, the study’s findings suggest that fish oil supplementation may have a beneficial effect on insulin resistance and blood sugar control in non-obese type 2 diabetes. The study provides valuable insights into the potential mechanisms by which fish oil supplementation may affect insulin resistance and highlights the importance of further research in this area.

Related Research

In recent years, several studies have explored the relationship between omega-3 fatty acids and type 2 diabetes. A 2024 analysis in the journal Nutrition and Diabetes used modeling data from 161 patients with type 2 diabetes to investigate the relationship between omega-3 levels and HbA1c, a longer-term marker of blood sugar control. The authors reported a dose-related association between omega-3 intake and HbA1c levels, suggesting that omega-3 fatty acids may have a beneficial effect on blood sugar control in type 2 diabetes.

Another study published in the journal Food and Function in 2025 explored the effects of fish oil supplementation on insulin resistance and metabolic health in healthy middle-aged and older adults. The study found that fish oil supplementation increased serum EPA and DHA levels and decreased fasting insulin levels, suggesting that fish oil may have a beneficial effect on insulin resistance and metabolic health.

These studies highlight the potential benefits of omega-3 fatty acids in the management and treatment of type 2 diabetes and suggest that further research is needed to explore the relationship between omega-3 intake and type 2 diabetes.